Morphic Holding (MORF) Competitor Comparison
We are evaluating the key criteria listed to compare Morphic Holding (MORF) against its competitors in the Biotechnology industry.
Market Capitalization
84 / 368Gross Profits
178 / 278Total Revenue
196 / 300EBITDA
255 / 337Free Cashflow
239 / 352Quick Ratio
6 / 357Earnings per Share
280 / 359Dividend yield
0 / 6Total Cash
37 / 358Performance 3 years
98 / 368Performance 5 years
58 / 368Performance 10 years
40 / 368Linearity 3 years
1 / 368Linearity 5 years
316 / 368Linearity 10 years
322 / 368Total Rank
204 / 368Dividend Rank
212 / 368Valuation Rank
219 / 368Piotroski Rank
88 / 368Muliplier Rank
161 / 368Linearity 3 years - MORF ranking 1 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.